Current Infectious Disease Reports

Scope & Guideline

Connecting Scholars to the Pulse of Infectious Disease Trends

Introduction

Explore the comprehensive scope of Current Infectious Disease Reports through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Current Infectious Disease Reports in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1523-3847
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1999 to 2024
AbbreviationCURR INFECT DIS REP / Curr. Infect. Dis. Rep.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

Current Infectious Disease Reports focuses on the dissemination of knowledge related to infectious diseases, emphasizing clinical, epidemiological, and therapeutic advancements. The journal aims to bridge the gap between research and practice, providing insights that impact patient care and public health strategies.
  1. Infectious Disease Epidemiology:
    The journal covers trends, outbreaks, and epidemiological studies related to various infectious diseases, helping to understand their spread and impact on populations.
  2. Clinical Management and Therapeutics:
    It emphasizes advancements in treatment strategies, including novel therapies and management protocols for infectious diseases, ensuring practitioners are informed about the latest clinical guidelines.
  3. Antimicrobial Stewardship and Resistance:
    A core focus is on antimicrobial resistance, exploring stewardship practices, resistance patterns, and the development of new therapeutic agents to combat resistant infections.
  4. Infection Prevention and Control:
    The journal provides insights into best practices for infection prevention in various settings, highlighting innovative approaches to reduce healthcare-associated infections.
  5. Global Health Perspectives:
    It addresses infectious diseases from a global perspective, emphasizing challenges faced in low- and middle-income countries, and the impact of social determinants on health.
Current Infectious Disease Reports has increasingly focused on emerging and re-emerging infectious diseases, reflecting the dynamic nature of global health challenges. Several themes have gained attention, indicating new research priorities.
  1. Emerging Viral Infections:
    A significant uptick in research addressing emerging viruses such as MPox and Marburg highlights the journal's commitment to understanding and managing new health threats.
  2. Impact of Climate Change on Infectious Diseases:
    Recent publications exploring the relationship between climate change and infectious disease outbreaks indicate an emerging focus on environmental health and its implications for infectious disease epidemiology.
  3. Invasive Fungal Infections:
    There is a growing interest in the management and treatment of invasive fungal infections, particularly in immunocompromised populations, reflecting broader concerns about fungal resistance and diagnostics.
  4. Artificial Intelligence in Infection Management:
    The integration of AI and advanced technologies in managing and predicting infectious disease outcomes is gaining traction, showcasing the journal's openness to innovative approaches.
  5. Antimicrobial Resistance and New Therapeutics:
    Research on antimicrobial resistance remains a priority, with an increased emphasis on developing new therapeutic agents and strategies to combat resistant infections.

Declining or Waning

While Current Infectious Disease Reports continues to evolve, certain themes have shown a decline in prominence over recent years. This may reflect shifting research priorities or changing public health needs.
  1. Traditional Antiviral Therapies:
    There is a noticeable decrease in publications focused on conventional antiviral medications, possibly due to the rise of novel therapies and the urgency of addressing emerging viruses.
  2. General Pediatric Infectious Diseases:
    Research specifically addressing common pediatric infections appears to be waning, as the focus has shifted towards more complex cases and emerging threats in pediatric populations.
  3. Surgical Infections and Postoperative Complications:
    The frequency of articles detailing traditional surgical site infections and management strategies has declined, indicating a potential shift towards more innovative or preventive approaches.
  4. Travel-related Infectious Diseases:
    While still relevant, the volume of articles specifically addressing travel-related infections has decreased, perhaps due to changes in travel patterns and public health responses to recent pandemics.
  5. Non-Communicable Diseases Related to Infectious Agents:
    Research linking infectious diseases to non-communicable diseases (e.g., cancers related to viral infections) has seen less focus, possibly overshadowed by more immediate infectious disease challenges.

Similar Journals

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Transforming Knowledge into Action for Infection Control
Publisher: CAMBRIDGE UNIV PRESSISSN: 0899-823XFrequency: 12 issues/year

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, published by Cambridge University Press, is a leading academic journal specializing in the critical fields of epidemiology, infectious diseases, and medical microbiology. With a history of publication dating back to 1988 and an expected continuation through 2024, the journal has established itself as a pivotal resource for researchers, healthcare professionals, and students alike. The journal's impact is reflected in its impressive rankings, positioning it in the second quartile for Epidemiology and the first quartile for both Infectious Diseases and Medical Microbiology as of 2023. This esteemed journal is dedicated to the dissemination of high-quality research that informs best practices in infection control and enhances patient safety across healthcare settings. Although access to its content is not open, the rigorous peer-review process ensures that all published articles contribute significantly to the body of knowledge in these vital areas. With a commitment to bridging the gap between research and practice, INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY remains an essential publication for those committed to the advancement of public health and the science of infection prevention.

Antimicrobial Resistance and Infection Control

Leading the charge in antimicrobial resistance research.
Publisher: BMCISSN: 2047-2994Frequency: 1 issue/year

Antimicrobial Resistance and Infection Control is a leading open access journal published by BMC, dedicated to the dissemination of research in the critical area of antimicrobial resistance and its impact on infection control practices. Since its inception in 2012, the journal has quickly established itself as a vital resource for researchers, healthcare professionals, and policymakers, featuring a robust array of studies that address the escalating threats posed by antimicrobial resistance across various contexts. With its impressive Q1 rankings across multiple categories—including Infectious Diseases, Microbiology, Pharmacology, and Public Health—the journal’s influence is underscored by its consistent placement in the upper echelons of academic research. Furthermore, it holds commendable ranks in Scopus, with percentiles placing it in the top tier of its respective fields. The journal serves as an essential platform for innovative research and discussions aimed at curbing the threats of antimicrobial resistance, thereby supporting the global health community in striving for effective solutions to safeguard public health.

AMERICAN JOURNAL OF INFECTION CONTROL

Empowering health professionals to combat infectious diseases.
Publisher: MOSBY-ELSEVIERISSN: 0196-6553Frequency: 10 issues/year

The American Journal of Infection Control is a leading peer-reviewed publication dedicated to advancing the field of infection prevention and control. Published by Mosby-Elsevier, this journal has been a crucial resource since its inception in 1980, focusing on the intersection of infectious diseases, public health, and health policy. As of 2023, it holds an impressive Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health, while also achieving Q2 rankings in Epidemiology and Infectious Diseases. With an increasing impact factor and a strong reputation reflected in its Scopus rankings, the journal appeals to researchers, health professionals, and students committed to preventing the spread of infections and enhancing healthcare safety. Although it does not currently offer Open Access, the journal ensures broad dissemination of its vital research through various subscription options. By fostering interdisciplinary collaboration and evidence-based practices, the American Journal of Infection Control plays a pivotal role in shaping effective infection control policies and practices worldwide.

Journal of the Pediatric Infectious Diseases Society

Uncovering the latest in pediatric infectious disease advancements.
Publisher: OXFORD UNIV PRESSISSN: 2048-7193Frequency: 4 issues/year

Journal of the Pediatric Infectious Diseases Society, published by Oxford University Press, stands as a pivotal platform for advancing knowledge in the realm of pediatric infectious diseases. With an ISSN of 2048-7193 and an E-ISSN of 2048-7207, this esteemed journal has garnered significant recognition in the academic community, achieving influential rankings such as Q1 in Pediatrics, Perinatology and Child Health and Q2 in Infectious Diseases. With converged years from 2012 to 2024, it aims to publish cutting-edge research, reviews, and clinical practices that address the challenges and innovations in the field. The journal's strong performance, reflected in its Scopus ranks (33rd percentile in Pediatrics and 97th in Infectious Diseases), underscores its impact on the global healthcare landscape. As a non-open access journal, it provides exclusive content essential for researchers, medical professionals, and students dedicated to enhancing pediatric healthcare outcomes.

New Microbes and New Infections

Advancing knowledge on the frontlines of infectious diseases.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Bridging Knowledge and Practice in Infectious Diseases
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0891-5520Frequency: 4 issues/year

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic resource in the field of infectious diseases and microbiology. With its ISSN 0891-5520 and E-ISSN 1557-9824, this esteemed journal has been at the forefront of disseminating critical research findings and clinical advancements since its inception in 1987. Known for its high impact, the journal ranks in the Q1 category for both Infectious Diseases and Medical Microbiology as of 2023, which underscores its significant contribution to advancing knowledge and practice in these vital areas. Researchers, practitioners, and students alike rely on its comprehensive yet concise reviews and original articles, ensuring they stay abreast of emerging trends and therapeutics in infectious disease management. Although it does not offer open access, the journal remains pivotal in enriching scholarly dialogue and influencing clinical practices in the United States and beyond. Explore this vital publication and join a community dedicated to excellence in infectious disease research.

INFECTIOUS DISEASES IN CLINICAL PRACTICE

Transforming clinical practice through scholarly excellence.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1056-9103Frequency: 6 issues/year

INFECTIOUS DISEASES IN CLINICAL PRACTICE, published by Lippincott Williams & Wilkins, is a crucial resource in the field of infectious diseases and microbiology. With an ISSN of 1056-9103 and an E-ISSN of 1536-9943, this journal has been a platform for scholarly communication since its inception in 1992, now spanning over two decades of continuous publication. The journal primarily focuses on the latest research developments, case studies, and clinical practices relevant to infectious diseases, making it an indispensable tool for researchers, healthcare professionals, and students alike. Although it is currently categorized in the Q4 quartile for both Infectious Diseases and Medical Microbiology, it continues to strive for excellence and relevance in a rapidly evolving field. By facilitating open access to impactful articles (note: Open Access not applicable), the journal aims to enhance global understanding and management of infectious diseases, ensuring that practitioners are well-equipped to confront contemporary challenges in this critical area of public health. Situated in the United States at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, INFECTIOUS DISEASES IN CLINICAL PRACTICE plays an essential role in fostering academic discourse and advancing clinical knowledge.

Infectious Disease Reports

Disseminating vital research for a healthier global community.
Publisher: MDPIISSN: Frequency: 6 issues/year

Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.

JOURNAL OF INFECTION AND CHEMOTHERAPY

Empowering Clinicians with Cutting-edge Insights
Publisher: ELSEVIERISSN: 1341-321XFrequency: 6 issues/year

JOURNAL OF INFECTION AND CHEMOTHERAPY, published by Elsevier, is a leading journal in the fields of Infectious Diseases, Microbiology, and Pharmacology. With a solid reputation reflected in its prestigious Q2 ranking in Infectious Diseases and Pharmacology, and Q3 in Microbiology (medical), this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and prevention of infectious diseases. The journal provides a platform for high-quality, peer-reviewed scholarly articles, making it an essential reference point in the medical community. Despite being published without open access, it continues to attract significant scholarly attention, as denoted by its rankings in Scopus, which showcases its impact within the academic landscape. With a timeline converging from 1995 to 2024, JOURNAL OF INFECTION AND CHEMOTHERAPY is dedicated to advancing knowledge and contributing to better health outcomes globally.

Journal of Infection Prevention

Enhancing health policy through rigorous scientific discourse.
Publisher: SAGE PUBLICATIONS LTDISSN: 1757-1774Frequency: 6 issues/year

Journal of Infection Prevention, published by SAGE Publications Ltd, is a pivotal resource in the fields of nursing, public health, and infectious diseases. With an ISSN of 1757-1774 and an E-ISSN of 1757-1782, this journal primarily serves as a platform for disseminating innovative research and comprehensive reviews aimed at enhancing infection control practices and health policy formulation. As of 2023, it holds a prestigious position within category quartiles, ranking Q2 in Advanced and Specialized Nursing and Q3 in Health Policy, Infectious Diseases, as well as Public Health, Environmental and Occupational Health, underscoring its relevance and influence in these arenas. Researchers, practitioners, and students are encouraged to explore the journal's content to contribute to the advancement of infection prevention strategies and the overall improvement of healthcare systems. With a convergence timeline from 2009 to 2024, the Journal of Infection Prevention is committed to publishing high-quality articles that address current challenges in infection control, thus playing a crucial role in the ongoing dialogue among health professionals.